| Size | Price | Stock | Qty |
|---|---|---|---|
| 100mg |
|
||
| 250mg |
|
||
| 500mg |
|
||
| Other Sizes |
| Targets |
Fluorescent dye
|
|---|---|
| ln Vitro |
Stock Solution Preparation
1. Protein Preparation To achieve optimal labeling efficiency, adjust the protein (antibody) concentration to 2 mg/mL. 1) The pH of the protein solution should be 8.5 ± 0.5. If the pH is below 8.0, adjust it using 1 M sodium bicarbonate. 2) If the protein concentration is below 2 mg/mL, labeling efficiency will be significantly reduced. A final protein concentration in the range of 2–10 mg/mL is recommended for optimal labeling efficiency. 3) The protein must be in a buffer that does not contain primary amines (e.g., Tris or glycine) or ammonium ions, as these may interfere with labeling efficiency. 2. Dye Preparation Dissolve the 5(6)-TAMRA dye in anhydrous DMSO to prepare a 10 mM stock solution. Mix thoroughly using a glass tube or by vortexing. Note: It is recommended to aliquot the 5(6)-TAMRA stock solution and store at –20 °C or –80 °C protected from light. Prior to use, the dye must be activated with a conjugation buffer (500 μg/mL) before proceeding with the labeling reaction. 3. Calculation of Dye Working Solution Volume The amount of 5(6)-TAMRA dye required for the labeling reaction depends on the amount of protein to be labeled. The optimal molar ratio of 5(6)-TAMRA dye to protein is approximately 10. Example: To label 500 μL of IgG at 2 mg/mL (MW = 150,000), dissolve 1 mg of 5(6)-TAMRA dye in 100 μL DMSO. The required volume of 5(6)-TAMRA is 2.88 μL. The calculation procedure is as follows: 1) mmol (IgG) = mg/mL (IgG) × mL (IgG) / MW (IgG) = 2 mg/mL × 0.5 mL / 150,000 mg/mmol = 6.7 × 10⁻⁶ mmol 2) mmol (5(6)-TAMRA) = mmol (IgG) × 10 = 6.7 × 10⁻⁶ mmol × 10 = 6.7 × 10⁻⁵ mmol 3) μL (5(6)-TAMRA) = mmol (5(6)-TAMRA) × MW (5(6)-TAMRA) / mg/μL (5(6)-TAMRA) = 6.7 × 10⁻⁵ mmol × 430.45 mg/mmol / 0.01 mg/μL = 2.88 μL Protocol 1. Labeling Reaction 1) Slowly add the calculated volume of freshly prepared 10 mg/mL 5(6)-TAMRA dye to 0.5 mL of the protein sample solution. Mix gently and briefly centrifuge to collect the sample at the bottom of the reaction tube. Avoid vigorous mixing to prevent protein denaturation and loss of activity. 2) Place the reaction tube in a dark place and incubate with gentle shaking at room temperature for 60 minutes. Every 10–15 minutes, gently invert the tube several times to thoroughly mix the reactants and improve labeling efficiency. 2. Protein Purification and Desalting The following protocol uses a Sephadex G-25 column for purifying the dye–protein conjugate. 1) Prepare the Sephadex G-25 column according to the manufacturer’s instructions. 2) Load the reaction mixture onto the top of the Sephadex G-25 column. 3) When the sample has run just below the surface of the top resin, immediately add PBS (pH 7.2–7.4). 4) Add more PBS (pH 7.2–7.4) to elute the desired sample. Collect the fractions containing the desired dye–protein conjugate. |
| References | |
| Additional Infomation |
5-carboxytetramethylrhodamine is a tetramethylrhodamine compound having a carboxy substituent at the 5-position. It has a role as a fluorochrome.
|
| Molecular Formula |
C25H22N2O5
|
|---|---|
| Molecular Weight |
430.45
|
| Exact Mass |
430.15287
|
| CAS # |
98181-63-6
|
| Related CAS # |
5(6)-TAMRA SE;246256-50-8
|
| PubChem CID |
2762602
|
| Appearance |
Brown to black solid powder
|
| Melting Point |
≥300ºC(lit.)
|
| LogP |
9.059
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
32
|
| Complexity |
875
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CN(C)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](C)C)C=C3O2)C4=C(C=C(C=C4)C(=O)[O-])C(=O)O
|
| InChi Key |
YMZMTOFQCVHHFB-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C25H22N2O5/c1-26(2)15-6-9-18-21(12-15)32-22-13-16(27(3)4)7-10-19(22)23(18)17-8-5-14(24(28)29)11-20(17)25(30)31/h5-13H,1-4H3,(H-,28,29,30,31)
|
| Chemical Name |
3-carboxy-4-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate
|
| Synonyms |
5-carboxytetramethylrhodamine; CHEBI:51657; RefChem:537820; 91809-66-4; ...; 5(6)-TAMRA Acid;
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ≥ 20.83 mg/mL (~48.39 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.08 mg/mL (4.83 mM) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3232 mL | 11.6158 mL | 23.2315 mL | |
| 5 mM | 0.4646 mL | 2.3232 mL | 4.6463 mL | |
| 10 mM | 0.2323 mL | 1.1616 mL | 2.3232 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.